Abstract
No public abstract is available from the verified source records.
Athiphat Banjongjit, Sudarat Seenamngoen, Somrath Srijaruneruang, Wachira Kochakarn, Bundit Sakulchairungrueng, Somchai Viengteerawat, Suwasin Udomkarnjananun
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Management of kidney transplant recipients by general nephrologists: core curriculum 2019
10.1053/j.ajkd.2019.01.031 · 2019
Impact of immunosenescence in older kidney transplant recipients: associated clinical outcomes and possible risk stratification for immunosuppression reduction
10.1007/s40266-024-01100-5 · 2024
Tacrolimus dose adjustment is not necessary in dose to dose conversion from a twice daily to a prolonged release once daily dose form
10.1038/s41598-022-14317-4 · 2022
Flat pattern peaks of tacrolimus absorption and associated pharmacogenomic variants in kidney transplantation recipients
10.3346/jkms.2022.37.e33 · 2022
CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
2018
Tacrolimus intrapatient variability, time in therapeutic range, and risk of de novo donor-specific antibodies
10.1097/tp.0000000000002913 · 2020
Fast Tac metabolizers at risk—it is time for a C/D ratio calculation
10.3390/jcm8050587 · 2019
No additional external references are available.
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%